Anika Therapeutics | Umsatzkosten



Cost Of Sales Veränderung Datum
Abbott USD 4.44B 502M 2025-03
Agios Pharmaceuticals USD 1.08M 175K 2025-03
Halozyme Therapeutics USD 48.4M 6.35M 2025-03
Insmed USD 21.28M 4.87M 2025-03
Integra LifeSciences USD 167.51M 9.29M 2025-03
J&J USD 7.3B 189M 2025-03
Ligand Pharmaceuticals USD 4.85M 2.01M 2025-03
MacroGenics USD 5.49M 3.62M 2024-12
Merit Medical Systems USD 733.32M 551.15M 2025-03
Sanofi EUR 2.89B 618M 2025-03
Smith & Nephew USD 911M 58M 2024-12
Stryker USD 2.12B 118M 2025-03
Veracyte USD 34.96M 4.91M 2025-03
Xencor 10.71M 4.56M 2024-09
Zimmer Biomet Holdings USD 586.7M 48.1M 2024-12



Anika Therapeutics Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.